Driving T cells to human atherosclerotic plaques: CCL3/CCR5 and CX3CL1/CX3CR1 migration axes
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Immunology"
DOI: 10.1002/eji.202049004
Abstract: The linkage of atherosclerosis to immune activation can be traced back as far as to Rudolf Virchow [1]. Cytokine release and alteration of surface marker expression on immune cells reflect this activation. Disorders characterized by… read more here.
Keywords: human atherosclerotic; atherosclerotic plaques; ccl3 ccr5; plaques ccl3 ... See more keywords
Ex vivo culture of human atherosclerotic plaques: A model to study immune cells in atherogenesis.
Sign Up to like & getrecommendations! Published in 2017 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2017.10.003
Abstract: BACKGROUND AND AIMS The mechanisms that drive atherosclerotic plaque progression and destabilization in humans remain largely unknown. Laboratory models are needed to study these mechanisms under controlled conditions. The aim of this study was to… read more here.
Keywords: human atherosclerotic; atherosclerotic plaques; study; model ... See more keywords
Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate With Plaque Vulnerability
Sign Up to like & getrecommendations! Published in 2021 at "Arteriosclerosis, Thrombosis, and Vascular Biology"
DOI: 10.1161/atvbaha.121.316091
Abstract: Supplemental Digital Content is available in the text. Objective: To determine whether MCP-1 (monocyte chemoattractant protein 1) levels in human atherosclerotic plaques associate with plaque vulnerability features. Approach and Results: We measured MCP-1 levels in… read more here.
Keywords: plaque; levels human; vulnerability; plaque vulnerability ... See more keywords
Effect of Chemically Modified Carbon-Coated Iron Nanoparticles on the Structure of Human Atherosclerotic Plaques Ex Vivo and on Adipose Tissue in Chronic Experiment In Vivo
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23158241
Abstract: The high mortality rate caused by atherosclerosis makes it necessary to constantly search for new and better treatments. In previous reports, chemically modified carbon-coated iron nanoparticles (Fe@C NPs) have been demonstrated a high biocompatibility and… read more here.
Keywords: vivo; structure; human atherosclerotic; chemically modified ... See more keywords